A new feature at the Christian Science Monitor explores how young women are leading the effort to end child marriage in Guatemala, highlighting the Population Council's Abriendo Oportunidades project.
Newsweek aggregates a recent report from the MIT Technology Review about the Council’s male contraceptive gel in development.
MIT Technology Review reports on the new male hormonal contraceptive gel developed by the Population Council in collaboration with the National Institute of Child Health and Human Development (NICHD) advancing to Phase II clinical trials.
In a post at the World Bank Education for Global Development blog, the Population Council's Stephanie Psaki, PhD expands on new research that indicates that gender parity in educational attainment may mask other important inequalities.
Recently, efforts to develop multi-purpose technologies (MPTs) have hit important milestones. At the New York Times "Women in the World," Pamela M. Norick details the Population Council's first in-human trial of griffithsin, a naturally occuring protein as one of the many exciting developments by intrepid doctors and scientists in the ongoing effort to prevent HIV.
Defending evidence isn't just important – it’s a necessity. Population Council president Julia Bunting illuminates the need for quality evidence and the uphill battle it currently faces in an op-ed featured at the Lancet Global Health blog.
_211_141.jpg)
Scientific American reports on Population Council’s upcoming international clinical trial of a Nestorone®/Testosterone gel, a novel reversible contraceptive for men.
Reporting from the 9th IAS Conference on HIV Science in Paris, a new article in Medscape discusses how HIV care is improving, but still failing many. The Council’s Nanlesta Pilgrim notes the key role that physicians must play when expanding access to Pre-exposure prophylaxis (PrEP).
